Peregrine Asset Advisers »

Regeneron Pharmaceuticals shares owned by Peregrine Asset Advisers

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Peregrine Asset Advisers from 13F filings

Historical chart of Peregrine Asset Advisers investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Peregrine Asset Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Peregrine Asset Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $266k 303 878.29
2023-09-30 $249k 303 822.96
2023-06-30 $218k 303 718.54
2023-03-31 $249k 303 821.67
2022-12-31 $507k 703 721.49
2021-09-30 $2.5M 4.2k 605.24
2020-06-30 $4.5M 7.2k 623.71
2020-03-31 $2.3M 4.6k 488.24